FDA testing indicates Zantac does not form carcinogen in users – NBCNews.com

The U.S. Food and Drug Administration on Friday downplayed the risk from contamination of the already recalled popular heartburn drug Zantac, and said its tests suggest it does not cause carcinogens to form in patients.
Janet Woodcock, director of the FDA’s …

Click here to view the original article.